THE INFLUENCE OF ENALAPRIL MALEAT AND METOPROLOL TREATMENT ON HEMODYNAMICS AND HEART RATE VARIABILITY INDECES AMONG PATIENTS WITH CHRONIC HEART FAILURE IN DIFFERENT AGES GROUP

  • О.V. Іgnatkina
  • I.D. Fedko
  • N.V. Lysenko
Keywords: chronic heart failure, heart rate variability, age, metoprolol, enalapril maleat

Abstract

During 1 st year in polyclinic 76 patients with chronic heart failure (HF) II-III FC were observed.  Mean age of patients 67,3±8,6 years-old and  they had a HF during 5,9+3,7 years. Various forms of chronic ischemic disease, arterial hypertension and its combination were reason of HF. The point of investigation was to study the efficiency in HF influence on its treatment by HF by enalapril maleat (EM) and metopolol (MT) on hemodynamics parameters and heart rate variability (HRV) among patient groups of different ages. The results we achieved, show, that the decrease of HRV parameters, caused by aging, is growing with HF appearance. EM is a medicine able to increase hemodynamical parameters without dependence of patient's age, and its positive influence on HRV shown most among middle-aged persons. The modelling influence of MT shown between all of the patients with HF not depending of their age

Downloads

Download data is not yet available.

References

1. Лазебник Л.Б., Постникова С.Л. // Русский медицинский журнал. 2002. №5. С. 12-17.

2. Dargie HJ; McMurray JJ; McDonagh TA. // J Intern Med Apr. 1996. № 239 (4). P 309-315.

3. Kannel WB, Belanger AJ. // Am Heart J. 1999. № 121. Р. 951-957.

4. Soejima K; Akaishi M; Meguro T. et al. // Jpn Circ J. 2000. Jan. № 64(1). Р. 32-38.

5. Nippon Ronen Igakkai. Heart rate variability analysis and neurobehavioral function in community-dwelling older people aged 75 or older Zasshi. 2002. Sep. № 39(5. Р. 520-526.

6. Яблучанский Н.И., Вакуленко И. П., Мартыненко А. В, и др. Интерпретация в клинической физи-ологии сердца. (Для настоящих врачей). - Харьков: изд-во Національного университетета внут-ренних дел. 2001. 168 с.

7. Heart rate variability. Standart of measurement, physiological, and clinical use. Task Force of European Society of Cardiology and The North American Society of Pacing and Electrophysiology // Europ. Heart J. 1996. Vol. 17. P. 354–381.

8. Migliaro ER; Contreras P; Bech S. et al. // Braz J Med Biol Res. 2001 Apr. № 34(4). Р. 493-500.

9. Agelink MW, Malessa R, Baumann B. // Clin Auton Res. 2001. Apr. № 11(2). Р. 99-108.

10. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. // N Engl J Med. 1991. № 325. Р. 293-302.

11. Беленков Ю.Н., Мареев В.Ю., Скворцов А.А. // Сердечная недостаточность. 2001. Т. 2. № 2.
How to Cite
ІgnatkinaО., Fedko, I., & Lysenko, N. (1). THE INFLUENCE OF ENALAPRIL MALEAT AND METOPROLOL TREATMENT ON HEMODYNAMICS AND HEART RATE VARIABILITY INDECES AMONG PATIENTS WITH CHRONIC HEART FAILURE IN DIFFERENT AGES GROUP. The Journal of V. N. Karazin Kharkiv National University, Series "Medicine", (6), 44-49. Retrieved from https://periodicals.karazin.ua/medicine/article/view/7296
Issue
No. 6 (2003)
Section
Clinical research

The Journal of V. N. Karazin Kharkiv National University, series Medicine has following copyright terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.